FDA warns J&J unit over device marketing

08/24/2010 | Los Angeles Times (tiered subscription model)

The FDA issued a warning letter to DePuy Orthopaedics saying that the Johnson & Johnson unit is selling an unapproved device, the TruMatch Personalized Solution System, and marketing another device, the Corail Hip System, for off-label uses. A DePuy statement said the company is "reviewing the letter to understand the FDA's concerns and will respond to their request for information."

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX